A 6-Month, Open-Label, Multi-Center, Flexible-Dose Extension Study to the B2061032 Study to Evaluate the Safety, Tolerability AND Efficacy of Desvenlafaxine Succinate Sustained-relaese (DVS SR) Tablets in the Treatment of Children ...